These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. RANKL-mediated osteoclastogenic differentiation of macrophages in the abdominal aorta of angiotensin II-infused apolipoprotein E knockout mice. Tanaka T; Kelly M; Takei Y; Yamanouchi D J Vasc Surg; 2018 Dec; 68(6S):48S-59S.e1. PubMed ID: 29685509 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of EP4 signaling attenuates aortic aneurysm formation. Yokoyama U; Ishiwata R; Jin MH; Kato Y; Suzuki O; Jin H; Ichikawa Y; Kumagaya S; Katayama Y; Fujita T; Okumura S; Sato M; Sugimoto Y; Aoki H; Suzuki S; Masuda M; Minamisawa S; Ishikawa Y PLoS One; 2012; 7(5):e36724. PubMed ID: 22570740 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm. Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137 [TBL] [Abstract][Full Text] [Related]
26. Exploration of the mechanisms by which 3,4-benzopyrene promotes angiotensin II-induced abdominal aortic aneurysm formation in mice. Ji K; Zhang Y; Jiang F; Qian L; Guo H; Hu J; Liao L; Tang J J Vasc Surg; 2014 Feb; 59(2):492-9. PubMed ID: 23676189 [TBL] [Abstract][Full Text] [Related]
27. Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms. Howatt DA; Dajee M; Xie X; Moorleghen J; Rateri DL; Balakrishnan A; Da Cunha V; Johns DG; Gutstein DE; Daugherty A; Lu H Circ J; 2017 May; 81(6):888-890. PubMed ID: 28420827 [TBL] [Abstract][Full Text] [Related]
28. Interleukin-5 is a potential mediator of angiotensin II-induced aneurysm formation in apolipoprotein E knockout mice. Xu J; Ehrman B; Graham LM; Eagleton MJ J Surg Res; 2012 Nov; 178(1):512-8. PubMed ID: 22459292 [TBL] [Abstract][Full Text] [Related]
29. Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused mice. Kim CW; Kumar S; Son DJ; Jang IH; Griendling KK; Jo H Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1412-21. PubMed ID: 24812324 [TBL] [Abstract][Full Text] [Related]
30. PPARδ reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice by regulating extracellular matrix homeostasis and inflammatory responses. Hwang JS; Kim HJ; Kim G; Kang ES; Ham SA; Yoo T; Paek KS; Yabe-Nishimura C; Kim HJ; Seo HG Int J Cardiol; 2014 Jun; 174(1):43-50. PubMed ID: 24698256 [TBL] [Abstract][Full Text] [Related]
31. Pharmacological Inhibition of MMP-12 Exerts Protective Effects on Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice. Di Gregoli K; Atkinson G; Williams H; George SJ; Johnson JL Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891996 [TBL] [Abstract][Full Text] [Related]
33. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Wang YX; Martin-McNulty B; da Cunha V; Vincelette J; Lu X; Feng Q; Halks-Miller M; Mahmoudi M; Schroeder M; Subramanyam B; Tseng JL; Deng GD; Schirm S; Johns A; Kauser K; Dole WP; Light DR Circulation; 2005 May; 111(17):2219-26. PubMed ID: 15851596 [TBL] [Abstract][Full Text] [Related]
34. Baicalein protects against the development of angiotensin II-induced abdominal aortic aneurysms by blocking JNK and p38 MAPK signaling. Wang F; Chen H; Yan Y; Liu Y; Zhang S; Liu D Sci China Life Sci; 2016 Sep; 59(9):940-9. PubMed ID: 27333787 [TBL] [Abstract][Full Text] [Related]
35. Age-Associated Sirtuin 1 Reduction in Vascular Smooth Muscle Links Vascular Senescence and Inflammation to Abdominal Aortic Aneurysm. Chen HZ; Wang F; Gao P; Pei JF; Liu Y; Xu TT; Tang X; Fu WY; Lu J; Yan YF; Wang XM; Han L; Zhang ZQ; Zhang R; Zou MH; Liu DP Circ Res; 2016 Oct; 119(10):1076-1088. PubMed ID: 27650558 [TBL] [Abstract][Full Text] [Related]
36. Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms. Mata KM; Tefé-Silva C; Floriano EM; Fernandes CR; Rizzi E; Gerlach RF; Mazzuca MQ; Ramos SG Cardiovasc Pathol; 2015; 24(2):110-20. PubMed ID: 25466491 [TBL] [Abstract][Full Text] [Related]
37. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix. Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006 [TBL] [Abstract][Full Text] [Related]
38. Down-regulation of Fibulin-5 is associated with aortic dilation: role of inflammation and epigenetics. Orriols M; Varona S; Martí-Pàmies I; Galán M; Guadall A; Escudero JR; Martín-Ventura JL; Camacho M; Vila L; Martínez-González J; Rodríguez C Cardiovasc Res; 2016 Jun; 110(3):431-42. PubMed ID: 27089918 [TBL] [Abstract][Full Text] [Related]
39. Abdominal Aortic Aneurysm-Associated MicroRNA-516a-5p Regulates Expressions of Methylenetetrahydrofolate Reductase, Matrix Metalloproteinase-2, and Tissue Inhibitor of Matrix Metalloproteinase-1 in Human Abdominal Aortic Vascular Smooth Muscle Cells. Chan CYT; Cheuk BLY; Cheng SWK Ann Vasc Surg; 2017 Jul; 42():263-273. PubMed ID: 28288890 [TBL] [Abstract][Full Text] [Related]
40. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Thompson RW; Baxter BT Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]